Dr. Mark E. Lawrence, D.O.
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- University of North Texas Hsc, College of Osteopathic Med (1989)
- Years since graduation
- 37
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 711
Licensed in Texas since 1990, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1989Medical school: University of North Texas Hsc, College of Osteopathic Med
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
TX license H8194 (first issued 1990; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Hendrick Medical Center Abilene, TX
- Hendrick Medical Center Brownwood Brownwood, TX
- Rolling Plains Memorial Hospital Sweetwater, TX
- Haskell Memorial Hospital Haskell, TX
- North Runnels Hospital Winters, TX
Medical groups
- Hendrick Provider Network (239 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 711
- Services billed
- 1,657
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 236 | 230 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 176 | 175 |
| Established patient office or other outpatient visit, 10-19 minutes | 115 | 112 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 112 | 110 |
| New patient office or other outpatient visit, 45-59 minutes | 102 | 99 |
| Repair of left upper heart chamber with implant with review by radiologist | 92 | 87 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 90 | 81 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 78 | 54 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 69 | 69 |
| Established patient office or other outpatient visit, 30-39 minutes | 62 | 55 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Temple, TX | 252 |
| Atorvastatin Calcium Other prescribers in Temple, TX | 252 |
| Eliquis (apixaban) Other prescribers in Temple, TX | 200 |
| Metoprolol Succinate Other prescribers in Temple, TX | 189 |
| Rosuvastatin Calcium Other prescribers in Temple, TX | 176 |
| Carvedilol Other prescribers in Temple, TX | 147 |
| Brilinta (ticagrelor) Other prescribers in Temple, TX | 98 |
| Losartan Potassium Other prescribers in Temple, TX | 96 |
| Amlodipine Besylate Other prescribers in Temple, TX | 93 |
| Furosemide Other prescribers in Temple, TX | 78 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 98 payments worth $2,044 in total to this clinician.
| Medtronic, Inc. | $822 |
|---|---|
| Edwards Lifesciences Corporation | $461 |
| Abiomed | $279 |
| Abbott Laboratories | $202 |
| Boston Scientific Corporation | $162 |
| Stryker Corporation | $72.15 |
| Cleerly, Inc. | $45.20 |
| Food and Beverage | $2,044 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $3,024 in research payments for these studies, mostly to the institutions running them.
- NCT05423379--XIENCE Skypoint Large Vessel Post Approval Study
Abbott Laboratories
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.